{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:02:31Z","timestamp":1788904951656,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100010166","name":"Xiamen Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["3502Z20224ZD1159"],"award-info":[{"award-number":["3502Z20224ZD1159"]}],"id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40268-024-00474-6","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T07:02:03Z","timestamp":1720076523000},"page":"317-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Exploring the Relationship Between Atorvastatin and Memory Loss: A Comprehensive Analysis Integrating Real-World Pharmacovigilance and Mendelian Randomization"],"prefix":"10.1007","volume":"24","author":[{"given":"Kaiqin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"issue":"6","key":"474_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1067\/mhj.2001.115587","volume":"141","author":"TJ Wang","year":"2001","unstructured":"Wang TJ, Stafford RS, Ausiello JC, Chaisson CE. Randomized clinical trials and recent patterns in the use of statins. Am Heart J. 2001;141(6):957\u201363. https:\/\/doi.org\/10.1067\/mhj.2001.115587.","journal-title":"Am Heart J"},{"issue":"7","key":"474_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2165\/00002018-200932070-00005","volume":"32","author":"C Do","year":"2009","unstructured":"Do C, Huyghe E, Lapeyre-Mestre M, Montastruc JL, Bagheri H. Statins and erectile dysfunction: results of a case\/non-case study using the French Pharmacovigilance System Database. Drug Saf. 2009;32(7):591\u20137. https:\/\/doi.org\/10.2165\/00002018-200932070-00005.","journal-title":"Drug Saf"},{"issue":"10","key":"474_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/s0828-282x(09)70715-9","volume":"25","author":"J Genest","year":"2009","unstructured":"Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult: 2009 recommendations. Can J Cardiol. 2009;25(10):567\u201379. https:\/\/doi.org\/10.1016\/s0828-282x(09)70715-9.","journal-title":"Can J Cardiol"},{"issue":"4","key":"474_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1345\/aph.1Q620","volume":"46","author":"CH Rojas-Fernandez","year":"2012","unstructured":"Rojas-Fernandez CH, Cameron JC. Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations. Ann Pharmacother. 2012;46(4):549\u201357. https:\/\/doi.org\/10.1345\/aph.1Q620.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"474_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4066\/AMJ.2015.2014","volume":"8","author":"AI Jamolowicz","year":"2015","unstructured":"Jamolowicz AI, Chen HY, Panegyres PK. Statins and memory loss: an Australian experience. Australas Med J. 2015;8(3):73\u20139. https:\/\/doi.org\/10.4066\/AMJ.2015.2014.","journal-title":"Australas Med J"},{"issue":"7","key":"474_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1592\/phco.23.7.871.32720","volume":"23","author":"LR Wagstaff","year":"2003","unstructured":"Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM. Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy. 2003;23(7):871\u201380. https:\/\/doi.org\/10.1592\/phco.23.7.871.32720.","journal-title":"Pharmacotherapy"},{"issue":"4","key":"474_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.21037\/cdt.2015.10.03","volume":"6","author":"K Takata","year":"2016","unstructured":"Takata K, Imaizumi S, Zhang B, Miura S, Saku K. Stabilization of high-risk plaques. Cardiovasc Diagn Ther. 2016;6(4):304\u201321. https:\/\/doi.org\/10.21037\/cdt.2015.10.03.","journal-title":"Cardiovasc Diagn Ther."},{"issue":"2","key":"474_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0008-6363(00)00247-9","volume":"49","author":"AM Lefer","year":"2001","unstructured":"Lefer AM, Scalia R, Lefer DJ. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. Cardiovasc Res. 2001;49(2):281\u20137. https:\/\/doi.org\/10.1016\/s0008-6363(00)00247-9.","journal-title":"Cardiovasc Res"},{"key":"474_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.778740","volume":"8","author":"LM Beltr\u00e1n Romero","year":"2021","unstructured":"Beltr\u00e1n Romero LM, Vallejo-Vaz AJ, Mu\u00f1iz GO. Cerebrovascular disease and statins. Front Cardiovasc Med. 2021;8: 778740. https:\/\/doi.org\/10.3389\/fcvm.2021.778740.","journal-title":"Front Cardiovasc Med."},{"issue":"1","key":"474_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12944-022-01747-2","volume":"21","author":"M Georgoulis","year":"2022","unstructured":"Georgoulis M, Chrysohoou C, Georgousopoulou E, Damigou E, Skoumas I, Pitsavos C, et al. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002\u20132012). Lipids Health Dis. 2022;21(1):141. https:\/\/doi.org\/10.1186\/s12944-022-01747-2.","journal-title":"Lipids Health Dis"},{"issue":"7","key":"474_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/14779072.2022.2094771","volume":"20","author":"AA Rizvi","year":"2022","unstructured":"Rizvi AA, Popovic DS, Papanas N, Pantea Stoian A, Al Mahmeed W, Sahebkar A, et al. Current and emerging drugs for the treatment of atherosclerosis: the evidence to date. Expert Rev Cardiovasc Ther. 2022;20(7):515\u201327. https:\/\/doi.org\/10.1080\/14779072.2022.2094771.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"9","key":"474_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/CIRCULATIONAHA.120.045851","volume":"142","author":"MJ Pencina","year":"2020","unstructured":"Pencina MJ, Pencina KM, Lloyd-Jones D, Catapano AL, Thanassoulis G, Sniderman AD. The expected 30-year benefits of early versus delayed primary prevention of cardiovascular disease by lipid lowering. Circulation. 2020;142(9):827\u201337. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.045851.","journal-title":"Circulation"},{"issue":"9601","key":"474_CR13","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","volume":"370","author":"J Armitage","year":"2007","unstructured":"Armitage J. The safety of statins in clinical practice. Lancet. 2007;370(9601):1781\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(07)60716-8.","journal-title":"Lancet"},{"issue":"8","key":"474_CR14","doi-asserted-by":"publisher","first-page":"C522","DOI":"10.1152\/ajpcell.00406.2014","volume":"309","author":"R Izadpanah","year":"2015","unstructured":"Izadpanah R, Sch\u00e4chtele DJ, Pfn\u00fcr AB, Lin D, Slakey DP, Kadowitz PJ, et al. The impact of statins on biological characteristics of stem cells provides a novel explanation for their pleiotropic beneficial and adverse clinical effects. Am J Physiol Cell Physiol. 2015;309(8):C522\u201331. https:\/\/doi.org\/10.1152\/ajpcell.00406.2014.","journal-title":"Am J Physiol Cell Physiol"},{"key":"474_CR15","doi-asserted-by":"publisher","unstructured":"Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45(4):645\u201354. https:\/\/doi.org\/10.1016\/j.jvs.2006.12.054 (discussion 653\u20134)","DOI":"10.1016\/j.jvs.2006.12.054"},{"issue":"9346","key":"474_CR16","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/s0140-6736(02)11600-x","volume":"360","author":"J Shepherd","year":"2002","unstructured":"Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623\u201330. https:\/\/doi.org\/10.1016\/s0140-6736(02)11600-x.","journal-title":"Lancet"},{"issue":"9","key":"474_CR17","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2174\/1381612820666141013134447","volume":"21","author":"I \u0160imi\u0107","year":"2015","unstructured":"\u0160imi\u0107 I, Reiner \u017d. Adverse effects of statins: myths and reality. Curr Pharm Des. 2015;21(9):1220\u20136. https:\/\/doi.org\/10.2174\/1381612820666141013134447.","journal-title":"Curr Pharm Des"},{"key":"474_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2147\/CLEP.S365513","volume":"14","author":"Y Shu","year":"2022","unstructured":"Shu Y, He X, Liu Y, Wu P, Zhang Q. A real-world disproportionality analysis of olaparib: data mining of the public version of FDA Adverse Event Reporting System. Clin Epidemiol. 2022;14:789\u2013802. https:\/\/doi.org\/10.2147\/CLEP.S365513.","journal-title":"Clin Epidemiol"},{"issue":"4","key":"474_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1248\/yakushi.21-00178-5","volume":"142","author":"D Nango","year":"2022","unstructured":"Nango D, Sekizuka T, Goto M, Echizen H. Analysis of Information on Drug Adverse Reactions Using US Food and Drug Administration Adverse Event Reporting System (FAERS). Yakugaku Zasshi. 2022;142(4):341\u20134. https:\/\/doi.org\/10.1248\/yakushi.21-00178-5.","journal-title":"Yakugaku Zasshi"},{"issue":"6","key":"474_CR20","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/ije\/dyx207","volume":"46","author":"VM Walker","year":"2017","unstructured":"Walker VM, Davey Smith G, Davies NM, Martin RM. Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities. Int J Epidemiol. 2017;46(6):2078\u201389. https:\/\/doi.org\/10.1093\/ije\/dyx207.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"474_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamacardio.2023.4115","volume":"9","author":"MG Levin","year":"2024","unstructured":"Levin MG, Burgess S. Mendelian randomization as a tool for cardiovascular research: a review. JAMA Cardiol. 2024;9(1):79\u201389. https:\/\/doi.org\/10.1001\/jamacardio.2023.4115.","journal-title":"JAMA Cardiol."},{"issue":"6","key":"474_CR22","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/14740338.2023.2172160","volume":"22","author":"Y Yavne","year":"2023","unstructured":"Yavne Y, Amar Shamir R, Shapiro M, Shepshelovich D. Evaluating the impact of black box warning updates on the reporting of drug-related adverse events: a cross sectional study of the FAERS database. Expert Opin Drug Saf. 2023;22(6):463\u20138. https:\/\/doi.org\/10.1080\/14740338.2023.2172160.","journal-title":"Expert Opin Drug Saf"},{"issue":"7944","key":"474_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318. https:\/\/doi.org\/10.1038\/s41586-022-05473-8.","journal-title":"Nature"},{"key":"474_CR24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.70382","volume":"11","author":"M Chong","year":"2022","unstructured":"Chong M, Mohammadi-Shemirani P, Perrot N, Nelson W, Morton R, Narula S, et al. GWAS and ExWAS of blood mitochondrial DNA copy number identifies 71 loci and highlights a potential causal role in dementia. Elife. 2022;11: e70382. https:\/\/doi.org\/10.7554\/eLife.70382.","journal-title":"Elife"},{"issue":"11","key":"474_CR25","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11):1274\u201383. https:\/\/doi.org\/10.1038\/ng.2797.","journal-title":"Nat Genet"},{"issue":"8","key":"474_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004;13(8):519\u201323. https:\/\/doi.org\/10.1002\/pds.1001.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"474_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"EP van Puijenbroek","year":"2002","unstructured":"van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(1):3\u201310. https:\/\/doi.org\/10.1002\/pds.668.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"474_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54(4):315\u201321. https:\/\/doi.org\/10.1007\/s002280050466.","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"474_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004141","volume":"19","author":"L Zagkos","year":"2022","unstructured":"Zagkos L, Dib MJ, Pinto R, Gill D, Koskeridis F, Drenos F, et al. Associations of genetically predicted fatty acid levels across the phenome: a Mendelian randomisation study. PLoS Med. 2022;19(12): e1004141. https:\/\/doi.org\/10.1371\/journal.pmed.1004141.","journal-title":"PLoS Med"},{"key":"474_CR30","doi-asserted-by":"publisher","first-page":"1125233","DOI":"10.3389\/fcell.2023.1125233","volume":"11","author":"S Wang","year":"2023","unstructured":"Wang S, Zhu H, Pan L, Zhang M, Wan X, Xu H, et al. Systemic inflammatory regulators and risk of acute-on-chronic liver failure: a bidirectional mendelian-randomization study. Front Cell Dev Biol. 2023;11:1125233. https:\/\/doi.org\/10.3389\/fcell.2023.1125233.","journal-title":"Front Cell Dev Biol."},{"issue":"23","key":"474_CR31","doi-asserted-by":"publisher","first-page":"9160","DOI":"10.1002\/cam4.3493","volume":"9","author":"X Chen","year":"2020","unstructured":"Chen X, Kong J, Diao X, Cai J, Zheng J, Xie W, et al. Depression and prostate cancer risk: a Mendelian randomization study. Cancer Med. 2020;9(23):9160\u20137. https:\/\/doi.org\/10.1002\/cam4.3493.","journal-title":"Cancer Med"},{"issue":"1","key":"474_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.amjopharm.2008.03.001","volume":"6","author":"JT Peters","year":"2008","unstructured":"Peters JT, Garwood CL, Lepczyk M. Behavioral changes with paranoia in an elderly woman taking atorvastatin. Am J Geriatr Pharmacother. 2008;6(1):28\u201332. https:\/\/doi.org\/10.1016\/j.amjopharm.2008.03.001.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"8","key":"474_CR33","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1592\/phco.26.8.1190","volume":"26","author":"L Galatti","year":"2006","unstructured":"Galatti L, Polimeni G, Salvo F, Romani M, Sessa A, Spina E. Short-term memory loss associated with rosuvastatin. Pharmacotherapy. 2006;26(8):1190\u20132. https:\/\/doi.org\/10.1592\/phco.26.8.1190.","journal-title":"Pharmacotherapy"},{"issue":"10","key":"474_CR34","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1345\/aph.1H014","volume":"40","author":"KP Padala","year":"2006","unstructured":"Padala KP, Padala PR, Potter JF. Simvastatin-induced decline in cognition. Ann Pharmacother. 2006;40(10):1880\u20133. https:\/\/doi.org\/10.1345\/aph.1H014.","journal-title":"Ann Pharmacother"},{"issue":"12","key":"474_CR35","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1592\/phco.23.15.1663.31953","volume":"23","author":"DS King","year":"2003","unstructured":"King DS, Wilburn AJ, Wofford MR, Harrell TK, Lindley BJ, Jones DW. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy. 2003;23(12):1663\u20137. https:\/\/doi.org\/10.1592\/phco.23.15.1663.31953.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"474_CR36","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1592\/phco.21.7.767.34577","volume":"21","author":"A Orsi","year":"2001","unstructured":"Orsi A, Sherman O, Woldeselassie Z. Simvastatin-associated memory loss. Pharmacotherapy. 2001;21(6):767\u20139. https:\/\/doi.org\/10.1592\/phco.21.7.767.34577.","journal-title":"Pharmacotherapy"},{"issue":"8","key":"474_CR37","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2165\/00002018-200730080-00003","volume":"30","author":"BA Golomb","year":"2007","unstructured":"Golomb BA, McGraw JJ, Evans MA, Dimsdale JE. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf. 2007;30(8):669\u201375. https:\/\/doi.org\/10.2165\/00002018-200730080-00003.","journal-title":"Drug Saf"},{"issue":"21","key":"474_CR38","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.jacc.2019.09.041","volume":"74","author":"K Samaras","year":"2019","unstructured":"Samaras K, Makkar SR, Crawford JD, Kochan NA, Slavin MJ, Wen W, et al. Effects of statins on memory, cognition, and brain volume in the elderly. J Am Coll Cardiol. 2019;74(21):2554\u201368. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.041.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"474_CR39","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1592\/phco.29.7.800","volume":"29","author":"MA Evans","year":"2009","unstructured":"Evans MA, Golomb BA. Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy. 2009;29(7):800\u201311. https:\/\/doi.org\/10.1592\/phco.29.7.800.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"474_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/17425255.2023.2235267","volume":"19","author":"B Zhao","year":"2023","unstructured":"Zhao B, Zhang X, Chen M, Wang Y. A real-world data analysis of acetylsalicylic acid in FDA Adverse Event Reporting System (FAERS) database. Expert Opin Drug Metab Toxicol. 2023;19(6):381\u20137. https:\/\/doi.org\/10.1080\/17425255.2023.2235267.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"47","key":"474_CR41","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","volume":"44","author":"SC Larsson","year":"2023","unstructured":"Larsson SC, Butterworth AS, Burgess S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J. 2023;44(47):4913\u201324. https:\/\/doi.org\/10.1093\/eurheartj\/ehad736.","journal-title":"Eur Heart J"},{"issue":"4","key":"474_CR42","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","volume":"5","author":"C Stancu","year":"2001","unstructured":"Stancu C, Sima A. Statins: mechanism of action and effects. J Cell Mol Med. 2001;5(4):378\u201387. https:\/\/doi.org\/10.1111\/j.1582-4934.2001.tb00172.x.","journal-title":"J Cell Mol Med"},{"key":"474_CR43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/978-90-481-8622-8_18","volume":"51","author":"G Saher","year":"2010","unstructured":"Saher G, Simons M. Cholesterol and myelin biogenesis. Subcell Biochem. 2010;51:489\u2013508. https:\/\/doi.org\/10.1007\/978-90-481-8622-8_18.","journal-title":"Subcell Biochem"},{"issue":"5","key":"474_CR44","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.2353\/ajpath.2009.080947","volume":"174","author":"VE Miron","year":"2009","unstructured":"Miron VE, Zehntner SP, Kuhlmann T, Ludwin SK, Owens T, Kennedy TE, et al. Statin therapy inhibits remyelination in the central nervous system. Am J Pathol. 2009;174(5):1880\u201390. https:\/\/doi.org\/10.2353\/ajpath.2009.080947.","journal-title":"Am J Pathol"},{"issue":"50","key":"474_CR45","doi-asserted-by":"publisher","first-page":"13609","DOI":"10.1523\/JNEUROSCI.2765-08.2008","volume":"28","author":"S Klopfleisch","year":"2008","unstructured":"Klopfleisch S, Merkler D, Schmitz M, Kl\u00f6ppner S, Schedensack M, Jeserich G, et al. Negative impact of statins on oligodendrocytes and myelin formation in vitro and in vivo. J Neurosci. 2008;28(50):13609\u201314. https:\/\/doi.org\/10.1523\/JNEUROSCI.2765-08.2008.","journal-title":"J Neurosci"},{"key":"474_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.03.010","volume":"154","author":"J Bouitbir","year":"2020","unstructured":"Bouitbir J, Sanvee GM, Panajatovic MV, Singh F, Kr\u00e4henb\u00fchl S. Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacol Res. 2020;154: 104201. https:\/\/doi.org\/10.1016\/j.phrs.2019.03.010.","journal-title":"Pharmacol Res"},{"issue":"2","key":"474_CR47","first-page":"77","volume":"62","author":"I Broniarek","year":"2016","unstructured":"Broniarek I, Jarmuszkiewicz W. Statins and mitochondria. Postepy Biochem. 2016;62(2):77\u201384.","journal-title":"Postepy Biochem"},{"issue":"1","key":"474_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/01.psy.0000151745.67285.c2","volume":"67","author":"PK Elias","year":"2005","unstructured":"Elias PK, Elias MF, D\u2019Agostino RB, Sullivan LM, Wolf PA. Serum cholesterol and cognitive performance in the Framingham Heart Study. Psychosom Med. 2005;67(1):24\u201330. https:\/\/doi.org\/10.1097\/01.psy.0000151745.67285.c2.","journal-title":"Psychosom Med"},{"issue":"2","key":"474_CR49","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1212\/01.wnl.0000103860.75218.a5","volume":"62","author":"S Kalmijn","year":"2004","unstructured":"Kalmijn S, van Boxtel MP, Ock\u00e9 M, Verschuren WM, Kromhout D, Launer LJ. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology. 2004;62(2):275\u201380. https:\/\/doi.org\/10.1212\/01.wnl.0000103860.75218.a5.","journal-title":"Neurology"},{"issue":"9","key":"474_CR50","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1212\/01.wnl.0000123250.82849.b6","volume":"62","author":"MC Morris","year":"2004","unstructured":"Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology. 2004;62(9):1573\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000123250.82849.b6.","journal-title":"Neurology"},{"issue":"1","key":"474_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0197-4580(02)00061-1","volume":"24","author":"CE Teunissen","year":"2003","unstructured":"Teunissen CE, De Vente J, von Bergmann K, Bosma H, van Boxtel MP, De Bruijn C, et al. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. Neurobiol Aging. 2003;24(1):147\u201355. https:\/\/doi.org\/10.1016\/s0197-4580(02)00061-1.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"474_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3233\/jad-2008-14202","volume":"14","author":"AC Granholm","year":"2008","unstructured":"Granholm AC, Bimonte-Nelson HA, Moore AB, Nelson ME, Freeman LR, Sambamurti K. Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J Alzheimers Dis. 2008;14(2):133\u201345. https:\/\/doi.org\/10.3233\/jad-2008-14202.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"474_CR53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jama.298.3.299","volume":"298","author":"BG Nordestgaard","year":"2007","unstructured":"Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299\u2013308. https:\/\/doi.org\/10.1001\/jama.298.3.299.","journal-title":"JAMA"},{"issue":"1","key":"474_CR54","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1212\/WNL.0000000000004749","volume":"90","author":"K N\u00e4gga","year":"2018","unstructured":"N\u00e4gga K, Gustavsson AM, Stomrud E, Lindqvist D, van Westen D, Blennow K, et al. Increased midlife triglycerides predict brain \u03b2-amyloid and tau pathology 20 years later. Neurology. 2018;90(1):e73-81. https:\/\/doi.org\/10.1212\/WNL.0000000000004749.","journal-title":"Neurology"},{"issue":"6","key":"474_CR55","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1037\/neu0000335","volume":"31","author":"V Parthasarathy","year":"2017","unstructured":"Parthasarathy V, Frazier DT, Bettcher BM, Jastrzab L, Chao L, Reed B, et al. Triglycerides are negatively correlated with cognitive function in nondemented aging adults. Neuropsychology. 2017;31(6):682\u20138. https:\/\/doi.org\/10.1037\/neu0000335.","journal-title":"Neuropsychology"},{"issue":"6","key":"474_CR56","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1177\/0271678X20968032","volume":"41","author":"F Sanjana","year":"2021","unstructured":"Sanjana F, Delgorio PL, Hiscox LV, DeConne TM, Hobson JC, Cohen ML, et al. Blood lipid markers are associated with hippocampal viscoelastic properties and memory in humans. J Cereb Blood Flow Metab. 2021;41(6):1417\u201327. https:\/\/doi.org\/10.1177\/0271678X20968032.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"32","key":"474_CR57","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459\u201372. https:\/\/doi.org\/10.1093\/eurheartj\/ehx144.","journal-title":"Eur Heart J"},{"issue":"1","key":"474_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J"},{"issue":"1","key":"474_CR59","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/eurjpc\/zwab154","volume":"29","author":"F Visseren","year":"2022","unstructured":"Visseren F, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2022;29(1):5\u2013115. https:\/\/doi.org\/10.1093\/eurjpc\/zwab154.","journal-title":"Eur J Prev Cardiol"},{"key":"474_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2023.103828","volume":"90","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Du Z, Qu K, Shen Y, Jiang Y, Zhu H, et al. Adverse events of epidiolex: a real-world drug safety surveillance study based on the FDA Adverse Event Reporting System (FAERS) database. Asian J Psychiatr. 2023;90: 103828. https:\/\/doi.org\/10.1016\/j.ajp.2023.103828.","journal-title":"Asian J Psychiatr"},{"issue":"2","key":"474_CR61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40290-020-00329-w","volume":"34","author":"TJ Moore","year":"2020","unstructured":"Moore TJ, Morrow RL, Dormuth CR, Mintzes B. US Food and Drug Administration safety advisories and reporting to the adverse event reporting system (FAERS). Pharmaceut Med. 2020;34(2):135\u201340. https:\/\/doi.org\/10.1007\/s40290-020-00329-w.","journal-title":"Pharmaceut Med."}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-024-00474-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40268-024-00474-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-024-00474-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T10:29:17Z","timestamp":1723199357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40268-024-00474-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1007\/s40268-024-00474-6","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"11 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by the Guidance in Medical and Health Program of Xiamen, China (3502Z20224ZD1159)\u00a0and Young Investigator Research Program of Xiang'an Hospital of Xiamen University (XAH23003).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Kaiqin Chen, Yongtai Chen, and Hesen Huang have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics\u00a0approval"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent\u00a0to\u00a0participate"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent\u00a0for\u00a0publication"}},{"value":"The datasets used and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability\u00a0of\u00a0data\u00a0and\u00a0material"}},{"value":"The code used and\/or analyzed during the current study is available from the corresponding author on reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code\u00a0availability"}},{"value":"HH:\u00a0conceptualization, methodology, software; KC: data curation, writing the original draft, visualization, investigation; YC:\u00a0supervision, data curation.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019\u00a0contributions"}}]}}